Hilton Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,041
| Closed | -$238K | – | 130 |
|
|
2025
Q4 | $238K | Sell |
1,041
-1,985
| -66% | -$452K | 0.02% | 157 |
|
|
2025
Q3 | $701K | Sell |
3,026
-264
| -8% | -$53.8K | 0.06% | 140 |
|
|
2025
Q2 | $611K | Sell |
3,290
-66
| -2% | -$12.3K | 0.05% | 144 |
|
|
2025
Q1 | $703K | Sell |
3,356
-37
| -1% | -$7.19K | 0.06% | 138 |
|
|
2024
Q4 | $603K | Sell |
3,393
-39
| -1% | -$7.17K | 0.05% | 142 |
|
|
2024
Q3 | $678K | Sell |
3,432
-143
| -4% | -$26.7K | 0.05% | 140 |
|
|
2024
Q2 | $613K | Buy |
3,575
+422
| +13% | +$69.9K | 0.05% | 135 |
|
|
2024
Q1 | $574K | Buy |
3,153
+758
| +32% | +$131K | 0.05% | 140 |
|
|
2023
Q4 | $371K | Hold |
2,395
| – | – | 0.04% | 137 |
|
|
2023
Q3 | $357K | Hold |
2,395
| – | – | 0.05% | 70 |
|
|
2023
Q2 | $323K | Hold |
2,395
| – | – | 0.04% | 67 |
|
|
2023
Q1 | $387K | Hold |
2,395
| – | – | 0.05% | 62 |
|
|
2022
Q4 | $321K | Hold |
2,395
| – | – | 0.04% | 59 |
|
|
2022
Q3 | $321K | Sell |
2,395
-823
| -26% | -$118K | 0.04% | 59 |
|
|
2022
Q2 | $493K | Sell |
3,218
-182
| -5% | -$27.8K | 0.06% | 57 |
|
|
2022
Q1 | $551K | Sell |
3,400
-118
| -3% | -$17.1K | 0.06% | 62 |
|
|
2021
Q4 | $476K | Sell |
3,518
-2,585
| -42% | -$305K | 0.04% | 69 |
|
|
2021
Q3 | $658K | Buy |
6,103
+2,614
| +75% | +$299K | 0.06% | 61 |
|
|
2021
Q2 | $393K | Buy |
3,489
+1
| +0% | +$113 | 0.04% | 80 |
|
|
2021
Q1 | $377K | Buy |
3,488
+144
| +4% | +$15.4K | 0.04% | 75 |
|
|
2020
Q4 | $358K | Sell |
3,344
-399
| -11% | -$38.3K | 0.04% | 65 |
|
|
2020
Q3 | $328K | Buy |
3,743
+110
| +3% | +$10.4K | 0.04% | 61 |
|
|
2020
Q2 | $357K | Sell |
3,633
-277
| -7% | -$24.4K | 0.04% | 63 |
|
|
2020
Q1 | $298K | Buy |
3,910
+647
| +20% | +$55.1K | 0.05% | 43 |
|
|
2019
Q4 | $289K | Buy |
3,263
+1,103
| +51% | +$91.6K | 0.03% | 82 |
|
|
2019
Q3 | $164K | Hold |
2,160
| – | – | 0.02% | 115 |
|
|
2019
Q2 | $157K | Hold |
2,160
| – | – | 0.02% | 120 |
|
|
2019
Q1 | $174K | Hold |
2,160
| – | – | 0.02% | 120 |
|
|
2018
Q4 | $199K | Hold |
2,160
| – | – | 0.04% | 113 |
|
|
2018
Q3 | $204K | Hold |
2,160
| – | – | 0.03% | 114 |
|
|
2018
Q2 | $200K | Hold |
2,160
| – | – | 0.03% | 121 |
|
|
2018
Q1 | $204K | Sell |
2,160
-2,500
| -54% | -$275K | 0.03% | 130 |
|
|
2017
Q4 | $451K | Hold |
4,660
| – | – | 0.07% | 85 |
|
|
2017
Q3 | $414K | Hold |
4,660
| – | – | 0.07% | 76 |
|
|
2017
Q2 | $338K | Buy |
+4,660
| New | +$313K | 0.06% | 74 |
|
|
2016
Q4 | – | Sell |
-24,962
| Closed | -$1.57M | – | 109 |
|
|
2016
Q3 | $1.57M | Buy |
+24,962
| New | +$1.62M | 0.39% | 39 |
|
Other funds holding ABBV
VCM
VPM
Hilton Capital Management's ABBV Position: Q1 2026 in Review
Hilton Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,041 shares — an estimated $238K sold.
Hilton Capital Management first reported a position in ABBV in Q3 2016 and held it in 36 quarters. The position peaked at $1.57M in Q3 2016. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Hilton Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- Hilton Capital Management sold 1,041 AbbVie shares in Q1 2026, an estimated $238K.
- Hilton Capital Management first reported a position in AbbVie in Q3 2016 and held it in 36 quarters.
- Hilton Capital Management's AbbVie position peaked at $1.57M in Q3 2016.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Hilton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.